Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about MannKind Corporation announces termination of license and collaboration agreement with Sanofi
MannKind Corporation announced the termination of its license and collaboration agreement with sanofi-aventis U.S. LLC for the development and commercialization of Afrezza® (insulin human) Inhalation Powder.
- Read more about Matinas BioPharma files IND application with US.FDA for MAT2501
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective therapeutics for the treatment of serious and life-threatening infections, announced that on December 31, 2015, the Company filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its lead antibacterial development candidate, MAT2501.
- Read more about Vericel Submits Biologics License Application to the FDA for MACI
Vericel Corporation, a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, announced that it has submitted a
- Read more about New drug for children's cancer found promising
Researchers have identified a powerful new drug with "unparalleled" strength against forms of a children's cancer that resist treatment.
- Read more about Sugar cut in fizzy drinks can prevent 3 lakh diabetes cases: Lancet
Cutting sugar in sweetened drinks by 40 percent can prevent over three lakh obesity-related Type 2 diabetes over the next two decades, a significant study has found.
- Read more about Oral contraceptive use doesn't lead to major birth defects
The use of oral contraceptive just before pregnancy is not associated with an increased risk of major birth defects, says a study.
- Read more about Low sunlight exposure increases cancer risk
Persons residing at higher latitudes, with lower sunlight exposure and greater prevalence of vitamin D deficiency, are at greater risk of developing cancer, including leukemia, a type of blood cancer, new research reveals.
- Read more about USFDA warns Cadila on lack of audit trails, torn notebooks, product mix-ups
Torn notebook recording deficiencies, lack of batch manufacturing records, use of unofficial notebooks, lack of audit trails on operation of computer systems, product mix-ups due to manufacturing deficiencies are some of the violations found by USFDA at Cadila Healthcare Ltd's two plants.
- Read more about Cipla to commercialize BioQ’s Ropivacaine Infusion System in India
BioQ Pharma and Cipla the signed of a strategic distribution, supply and development agreement for the registration and commercialization of BioQ Pharma's Ropivacaine infusion pharmaceutical in India.

(adsbygoogle = window.adsbygoogle || []).push({});
- Read more about BioQ Pharma Enter into an Agreement with Cipla
BioQ Pharma Incorporated, a specialty pharmaceutical company focused on the development and commercialization of single-use, large-volume ready-to-use infusible pharmaceuticals, and Cipla Limited, “Cipla,” a global pharmaceutical company that uses cutting edge technology and innovation to meet the everyday needs of all patients, announced the signing of a strategic distribution, supply and development agreement for the registration and commercialization of BioQ Pharma's Ropivacaine infusion pharmaceutical in India.